1. Suppression of cancer stemness by upregulating Ligand-of-Numb protein X1 in colorectal carcinoma
   Lin Ma et al, 2017, PLoS ONE CrossRef
2. Cytotoxic effects of the newly-developed chemotherapeutic agents 17-AAG in combination with oxaliplatin and capecitabine in colorectal cancer cell lines
   Mahshid Mohammadian et al, 2017, Res Pharma Sci CrossRef
3. RXRα-enriched cancer stem cell-like properties triggered by CDDP in head and neck squamous cell carcinoma (HNSCC)
   Pan Jiang et al, 2017 CrossRef
4. Potential therapeutic targets for growth arrest of colorectal cancer cells exposed to PTHrP
   María Julia Martín et al, 2018, Molecular and Cellular Endocrinology CrossRef
5. Role of transmembrane glycoprotein mucin 1 (MUC1) in various types of colorectal cancer and therapies: Current research status and updates.
   Mei Guo et al, 2018, Biomed Pharmacother CrossRef
6. The Phenolic compound Kaempferol overcomes 5-fluorouracil resistance in human resistant LS174 colon cancer cells
   Ichrak Riahi-Chebbi et al, 2019, Sci Rep CrossRef
7. CD26/DPP4 - a potential biomarker and target for cancer therapy
   Njanja Enz et al, 2019, Pharmacology & Therapeutics CrossRef
8. Inhibition of PGE2/EP4 receptor signaling enhances oxaliplatin efficacy in resistant colon cancer cells through modulation of oxidative stress
   Huakang Huang et al, 2019, Sci Rep CrossRef
9. Overcoming acquired resistance of gefitinib in lung cancer cells without T790M by AZD9291 or Twist1 knockdown in vitro and in vivo
   Zhongwei Liu et al, 2019, Arch Toxicol CrossRef
10. Contribution of nuclear events in generation and maintenance of cancer stem cells: revisiting chemo-resistance
    Argha Manna et al, 2017, Nucleus CrossRef
11. Targeting cancer stem cells in squamous cell carcinoma
    Demeng Chen et al, 2019 CrossRef
12. Redox-Mediated Mechanism of Chemoresistance in Cancer Cells
    Eun-Kyung Kim et al, 2019, Antioxidants CrossRef
13. Synthesis and characterisation of a novel mono functionalisable Pt(IV) oxaliplatin-type complex and its peptide conjugate
    Eolann Kitteringham et al, 2020, Inorganica Chimica Acta CrossRef
14. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
    Sabrina Dallavalle et al, 2020, Drug Resist Updat CrossRef
15. Targeting CD133 reverses drug-resistance via the AKT/NF-κB/MDR1 pathway in colorectal cancer
    Zeting Yuan et al, 2020, Br J Cancer CrossRef
16. Effects of long non-coding RNA Opa-interacting protein 5 antisense RNA 1 on colon cancer cell resistance to oxaliplatin and its regulation of microRNA-137
    Jing Liang et al, 2020, WJG CrossRef
17. Inhibition of 3D colon cancer stem cell spheroids by cytotoxic RuII-p-cymene complexes of mesalazine derivatives
    Sourav Acharya et al, 2020, Chem. Commun. CrossRef
18. Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1
    Andrew Fesler et al, 2018, Oncotarget CrossRef
19. RNA sequencing reveals upregulation of a transcriptomic program associated with stemness in metastatic prostate cancer cells selected for taxane resistance.
    Christina K Cajigas-Du Ross et al, 2018, Oncotarget CrossRef
20. Meta-analysis indicating that high ALCAM expression predicts poor prognosis in colorectal cancer
    Yeqing Zhang et al, 2017, Oncotarget CrossRef
21. Influence of Innate Immunity on Cancer Cell Stemness
    Anna Pastò et al, 2020, IJMS CrossRef
22. The interaction of light-activatable 2-thioxanthone thioacetic acid with ct-DNA and its cytotoxic activity: Novel theranostic agent
    Nese Ataci et al, 2020, Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy CrossRef
23. Revolutionizing the landscape of colorectal cancer treatment: The potential role of immune checkpoint inhibitors
    Mai F. Tolba, 2020, Int. J. Cancer CrossRef
24. MT2A Promotes Oxaliplatin Resistance in Colorectal Cancer Cells
    Zhicheng Zhao et al, 2020, Cell Biochem Biophys CrossRef
25. Exploiting fourier transform infrared and Raman microspectroscopies on cancer stem cells from oral squamous cells carcinoma: new evidence of acquired cisplatin chemoresistance
    Valentina Notarstefano et al, 2020, Analyst CrossRef
26. 8-Hydroxyquinoline platinum(ii) loaded nanostructured lipid carriers: synthesis, physicochemical characterization and evaluation of antitumor activity
    T. Boztepe et al, 2021, New J. Chem. CrossRef
27. SILAC-Based Quantitative Proteomic Analysis of Oxaliplatin-Resistant Pancreatic Cancer Cells
    Young Eun Kim et al, 2021, Cancers CrossRef
28. Exploiting the Acidic Extracellular pH: Evaluation of Streptococcus salivarius M18 Postbiotics to Target Cancer Cells
    Sevinç Karaçam et al, 2021, Probiotics & Antimicro. Prot. CrossRef
29. Novel N-Substituted Amino Acid Hydrazone-Isatin Derivatives: Synthesis, Antioxidant Activity, and Anticancer Activity in 2D and 3D Models In Vitro
    Ingrida Tumosienė et al, 2021, IJMS CrossRef
30. The Clinical and Theranostic Values of Activated Leukocyte Cell Adhesion Molecule (ALCAM)/CD166 in Human Solid Cancers
    Yiming Yang et al, 2021, Cancers CrossRef
31. Biochemical and Cellular Characterization of New Radio-Resistant Cell Lines Reveals a Role of Natural Flavonoids to Bypass Senescence
    Maria Russo et al, 2021, IJMS CrossRef
32. Antioxidant Activity of Phytochemicals in Cancer
    Shreyas R. Gaikwad et al, 2022 CrossRef
33. Aldehyde Dehydrogenase 2 Family Member (ALDH2) Is a Therapeutic Index for Oxaliplatin Response on Colorectal Cancer Therapy with Dysfunction p53
    Wei-Lin Wang et al, 2022, BioMed Research International CrossRef
34. DNAJB8 in small extracellular vesicles promotes Oxaliplatin resistance through TP53/MDR1 pathway in colon cancer
    Zheng Wang et al, 2022, Cell Death Dis CrossRef
35. CLEISTANTHIN B SHOWS A POTENT CYTOTOXIC ACTIVITY AGAINST COLORECTAL CANCER CELLS
    PULI SAGAR et al, 2022, Asian J Pharm Clin Res CrossRef
36. Implication of Different Tumor Biomarkers in Drug Resistance and Invasiveness in Primary and Metastatic Colorectal Cancer Cell Lines
    Marta Sánchez-Díez et al, 2022, Biomedicines CrossRef
37. The TH1902 Docetaxel Peptide-Drug Conjugate Inhibits Xenografts Growth of Human SORT1-Positive Ovarian and Triple-Negative Breast Cancer Stem-like Cells
    Michel Demeule et al, 2022, Pharmaceutics CrossRef
38. Identification of Novel miRNAs, Targeting Genes, Signaling Pathway, and the Small Molecule for Overcoming Oxaliplatin Resistance of Metastatic Colorectal Cancer
    Md Misbah et al, 2022, BioMed Research International CrossRef
39. Antioxidant Activity of Phytochemicals in Cancer
    Shreyas R. Gaikwad et al, 2022 CrossRef
40. Cancer stem cells in colorectal cancer: signaling pathways involved in stemness and therapy resistance
    Nasim Ebrahimi et al, 2023, Critical Reviews in Oncology/Hematology CrossRef
41. DNA groove binder and significant cytotoxic activity on human colon cancer cells: Potential of a dimeric zinc (II) phthalocyanine derivative
    Gonul S. Batibay et al, 2023, Biophysical Chemistry CrossRef
42. Antiproliferative Activities of Acetone Extract From Canarium Odontophyllum (Dabai) Stem Bark Against Human Colorectal Cancer Cells
    Siti Fairuz Ishak et al, 2023, Dose-Response CrossRef
43. Antioxidant, Immunostimulatory, and Anticancer Properties of Hydrolyzed Wheat Bran Mediated through Macrophages Stimulation
    Irene Tomé-Sánchez et al, 2023, IJMS CrossRef
44. The pathological role of C-X-C chemokine receptor type 4 (CXCR4) in colorectal cancer (CRC) progression; special focus on molecular mechanisms and possible therapeutics
    Ahmed Hjazi et al, 2023, Pathology - Research and Practice CrossRef
45. Optimization of Clove Oil Nanoemulsions: Evaluation of Antioxidant, Antimicrobial, and Anticancer Properties
    José Nabor Haro-González et al, 2023, Colloids and Interfaces CrossRef
46. Insights into the molecular mechanisms and signalling pathways of epithelial to mesenchymal transition (EMT) in colorectal cancer: A systematic review and bioinformatic analysis of gene expression
    Suha Azizan et al, 2023, Gene CrossRef
47. Synthetic derivatives of natural cinnamic acids as potential anti‐colorectal cancer agents
    Federica Falbo et al, 2024, Chem Biol Drug Des CrossRef
48. Cell Death, by Any Other Name…
    Mustapha Kandouz, 2024, Cells CrossRef
49. Potential role of the Eph/ephrin system in colorectal cancer: emerging druggable molecular targets
    João Figueira Scarini et al, 2024, Front. Oncol. CrossRef
50. Comprehensiveness cuproptosis related genes study for prognosis and medication sensitiveness across cancers, and validation in prostate cancer
    Longfei Yang et al, 2024, Sci Rep CrossRef
51. Short-chain fructooligosaccharides synthesis using a commercial enzyme complex from Aspergillus sp. and anti-cancer activity on HCT116 and HT-29 cell lines
    Meda Bytautaitė et al, 2024, Food Bioscience CrossRef
52. Assessing cytotoxic activities, theoretical and in silico molecular docking calculations of phthalocyanines bearing cinnamyloxy-groups
    Özge Özten et al, 2024, Journal of Biomolecular Structure and Dynamics CrossRef